IOL Chemicals Promoter Group Entity Mayadevi Polycot Limited Discloses Shareholding Changes
Maya devi Polycot Limited, a promoter group entity of IOLCP, sold 54,197 equity shares on March 18, 2026. Their shareholding decreased from 21.78% to 21.76%. The disclosure was made on March 19, 2026.
The change in shareholding is marginal (0.02%) and involves a promoter group entity, which is a common occurrence and unlikely to significantly impact the company's stock price or operations.
The disclosure reports a change in shareholding by a promoter group entity, which is a routine regulatory filing and does not inherently indicate positive or negative news for the company.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has received disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, from Maya devi Polycot Limited, an entity within the Promoter Group. The disclosure pertains to changes in the shareholding of Maya devi Polycot Limited.
Prior to the acquisition/disposal, Maya devi Polycot Limited held 6,39,45,330 equity shares, representing 21.78% of the total shareholding. Following the transaction, their holding has adjusted to 6,38,91,133 equity shares, which constitutes 21.76% of the total shareholding. The change involved the sale of 54,197 equity shares on the 18th of March 2026, executed on the market.
This disclosure was intimated to the company on March 19th, 2026. The company has acknowledged the receipt of these disclosures.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under shareholding pattern. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.